Aberrant PAX3 and PAX7 expression. A link to the metastatic potential of embryonal rhabdomyosarcoma and cutaneous malignant melanoma?

Histology and Histopathology

Volumn 18, Issue 2, 2003, Pages 529-539

  Blake, J ^a   Ziman, Mel R ^a  

^a EDITH COWAN UNIVERSITY   (Australia)

Author keywords

Developmental genes; Metastasis; NCAM and ephrins; Pax genes

Indexed keywords

BIOLOGICAL MARKER; EPHRIN; EPHRIN RECEPTOR; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG;

CANCER; CELL ADHESION; CELL MIGRATION; CELL SURFACE; CHROMOSOME ABERRATION; CLINICAL FEATURE; CYTOGENETICS; EMBRYO DEVELOPMENT; EMBRYO SEGMENTATION; EMBRYONAL RHABDOMYOSARCOMA; GENE; GENE FUNCTION; GENE MUTATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; MELANOMA; METASTASIS; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; REVIEW; STEM CELL;

ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MELANOMA; MEMBRANE PROTEINS; NEOPLASM METASTASIS; NEURAL CELL ADHESION MOLECULES; PAIRED BOX TRANSCRIPTION FACTORS; PAX7 TRANSCRIPTION FACTOR; RECEPTORS, EPH FAMILY; RHABDOMYOSARCOMA, EMBRYONAL; SKIN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0037378004     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Altman A.J. and Schwartz A.D. (1983). Malignant Diseases of Infancy, Childhood and Adolescence. Saunders. Philadelphia. pp. 424-434.
2. Astolfi A., De Giovanni C., Landuzzi L., Nicoletti G., Ricci C., Croci S., Scopece L., Nanni P. and Lollini P.L. (2001). Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells. Gene 274, 139-149.
3. Bale S.J., Chakravarti A. and Greene M.H. (1986). Cutaneous malignant melanoma and familial dysplastic nevi: Evidence for autosomal dominance and pleiotropy. Am. J. Hum. Genet. 38, 188-196.
4. Bale S.J., Dracopoli N.C., Tucker M.A., Clark W.H., Fraser M.C., Stanger B.Z., Green P., Donis-Keller H., Housman D.E. and Greene M.H. (1989). Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. New Engl. J. Med. 320, 1367-1372.
5. Baker K.S., Anderson J.R., Link M.P., Grier H.E., Qualman S.J., Maurer H.M., Breneman J.C., Wiener E.S. and Crist W.M. (2000). Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: Results from the Intergroup Rhabdomyosarcoma Study IV. J. Clin. Oncol. 18, 2427-2434.
6. Barber, T.D., Barber M.C., Cloutier T.E. and Friedman T.B. (1999). PAX3 gene structure, alternative splicing and evolution. Gene 237, 311-319.
7. Barr F.G., Fitzgerald J.C., Ginsberg J.P., Vanella M.L., Davis R.J. and Bennicelli J.L. (1999). Predominant expression of PAX3 and PAX7 forms in myogenic and neural tumor cell lines. Cancer Res. 59, 5443-5448.
8. Bennicelli M., Edwards R.H. and Barr F.G. (1996). Mechanisms for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. Proc. Natl. Acad. Sci. USA 93, 5455-5459.
9. Bentley N.J., Eisen T. and Goding C.R. (1994). Melanocyte-specific expression of the human tyrosinase promoter: Activation by the microphthalmia gene product and role of the initiator. Mol. Cell Biol. 14, 7996-8006.
10. Bittner M., Metlzer P., Chen Y., Jiang Y., Seftor E., Hendrix M., Radmacher M., Simon R., Yakhini Z., Ben-Dor A., Sampas N., Dougherty E., Wang E., Marincola F., Gooden C., Lueders J., Glatfelter A., Pollock P., Carpten J., Gillanders E., Leja D., Dietrich K., Beaudry C., Berens M., Alberts D. and Sondak V. (2000). Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536-540.
11. Bopp D., Burri M., Baumgartner S., Frigerio G. and Noll M. (1986). Conservation of a large protein domain in the segmentation gene paired and in functionally related genes of Drosophila. Cell 47, 1033-1040.
12. Bridge J., Liu J., Qualman S., Suijkerbuijk R., Wenger G., Zhang J., Wan X., Baker S., Sorensen P. and Barr F. (2002). Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Gene Chromosome Cancer 33, 310-321.
13. Burri M., Tromvoukis Y., Bopp D., Frigerio G. and Noll M. (1989). Conservation of the paired domain in metazoans and its structure in three isolated human genes. EMBO J. 4, 1183-1190.
14. Celli P., Cervoni L. and Maraglino C. (1998). Primary rhabdomyosarcoma of the brain: Observations on a case with clinical and radiological evidence of cure. J. Neuro-Oncol. 36, 259-267.
15. Chalepakis G., Stoykova A., Wijnholds J., Tremblay P. and Gruss P. (1993). Pax: Gene regulators in the developing nervous system. J. Neurobiol. 24, 1367-1384.
16. Chalepakis G., Jones F.S., Edelman G.M. and Gruss P. (1994). Pax-3 contains domains for transcription activation and transcription inhibition. Proc. Natl. Acad. Sci. USA 91, 12745-12749.
17. Cheng N., Brantley D.M. and Chen J. (2002). The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev. 13, 75-85.
18. Chiari R., Hames G., Stroobant V., Texier C., Maillere B., Boon T. and Coulie P. (2000). Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T Cells on HLA Class II molecules. Cancer Res. 60, 4855-4863.
19. Coulthard M.G., Duffy S., Down M., Evans B., Power M., Smith F., Stylianou C., Kleikamp S., Oates A., Lackmann M., Burns G.F. and Boyd A.W. (2002). The role of the Eph-ephrin signalling system in the regulation of developmental patterning. Int. J. Dev. Biol. 46, 375-384.
20. Cunningham B.A., Hemperly J.J., Murray B.A., Prediger E.A., Brackenbury R. and Edelman G.M. (1987). Neural cell adhesion molecule: Structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science 6, 799-806.
21. DeVita V.T., Young R.C. and Canellos G.P. (1975). Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer. Cancer 35, 98.
22. Dracopoli N.C., Bale S.J and Housman D.E. (1989). Assignment of the familial melanoma gene to chromosome 1p36: Frequent loss of heterozygosity of this region occurs late in tumor progression. Am. J. Hum. Genet. 45, A19.
23. Dressler G.R. and Douglass E.C. (1992). Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc. Natl. Acad. Sci. USA 89, 1179-1183.
24. Easty D.J. and Bennett D.C. (2000). Protein tyrosine kinases in malignant melanoma. Melanoma Res. 10, 401-411.
25. Easty D.J., Herlyn M. and Bennett D.C. (1995). Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis. Int. J. Cancer 60, 129-136.
26. Easty D.J., Mitchell P.J., Patel K., Florenes V.A., Spritz R.A. and Bennett D.C. (1997). Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma. Int. J. Cancer 71, 1061-1065.
27. Easty D.J., Hill S.P., Hsu M., Fallowfield M.E., Florenes V., Herlyn M. and Bennett D.C. (1999). Up- regulation of ephrin- a1 during melanoma progression. Int. J. Cancer 84, 494-501.
28. Edelman G.M. and Crossin K.L. (1991). Cell adhesion molecules: Implications for a molecular histology. Annu. Rev. Biochem. 60, 155-190.
29. Edelman G.M. and Jones F.S. (1995). Developmental control of N-CAM expression by Hox and Pax gene products. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 349, 305-312.
30. Eph Nomenclature Committee. (1997). United nomenclature for Eph family receptors and their ligands, the ephrins. Cell 90, 403-404.
31. Epstein D.J., Malo D., Vekemans M. and Gros P. (1991). Molecular characterization of a deletion encompassing the splotch mutation on mouse chromosome 1. Genomics 10, 89-93.
32. Fidler I.J. (1978). Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res. 38, 2651-2660.
33. Fountain J.W., Bale S.J., Housman D.E. and Dracopoli N.C. (1990). Genetics of melanoma. Cancer Surv. 9, 645-671.
34. Franz T. (1990). Defective ensheathment of motoric nerves in the splotch mutant mouse. Acta Anat. 138, 246-252.
35. Fukuda T., Kawano H., Osumi N., Eto K. and Kawamura K. (2000). Histogenesis of the cerebral cortex in rat fetuses with a mutation in the Pax-6 gene. Brain Res. Dev. Brain Res. 120, 65-75.
36. Gale N.W., Holland S.J., Valenzuela D.M., Flenniken A., Pan L., Ryan T.E., Henkemeyer M., Strebhardt K., Hirai H., Wilkinson D.G., Pawson T., Davis S. and Yancopoulos G.D. (1996). Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 17, 9-19.
37. Galibert M.D., Yavuzer U., Dexter T.J. and Goding C.R. (1999). Pax3 and regulation of the -specific tyrosinase-related protein-1 promoter. J. Biol. Chem. 274, 26894-26900.
38. Gilcrest B.A., Eller M.S., Geller A.C. and Yaar M. (1999). The pathogenesis of melanoma induced by ultraviolet radiation. New Engl. J. Med. 340, 1341-348.
39. Gluer S, Zense M. and Von Schweinitz D. (1998a). Cell adhesion molecules and intermediate filaments on embryonal childhood tumors. Pathol. Res. Pract. 194, 773-780.
40. Gluer S., Schelp C., Von Schweinitz D. and Gerardy-Schahn R. (1998b). Polysialylated neural cell adhesion molecule in childhood rhabdomyosarcoma. Pediatr. Res. 43, 145-147.
41. Goulding M.D., Chalepakis G., Deutsch U., Erselius J.R. and Gruss P. (1991). Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10, 1135-1147.
42. Greene M.H., Clark W.H., Tucker M.A., Elder D.E., Kraemer K.H., Guerry D., Witmer W.K., Thompson J., Matozzo I. and Fraser M.C. (1985). Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N. Engl. J. Med. 312, 91-97.
43. Gruss P. and Walther C. (1992). Pax in development. Cell 69, 719-722.
44. Hattori M., Osterfield M. and Flanagan J.G. (2000). Regulated cleavage of contact- mediated axon repellent. Science 289, 1360-1365.
45. Henderson D.J., Conwan S.J. and Copp A.J. (1999). Rib truncations and fusions in the Sp2H mouse reveal a role for Pax3 in specification of the ventro-lateral and posterior parts of the somite. Dev. Biol. 209, 143-158.
46. Holst B.D., Wang Y., Jones F.S. and Edelman G.M. (1997). A binding site for Pax proteins regulates expression of the gene for the neural cell adhesion molecule in the embryonic spinal cord. Proc. Natl. Acad. Sci. USA 94, 1465-1470.
47. Honda H. and Mochizuki A. (2002). Formation and maintenance of distinctive cell patterns by coexpression of membrane- bound ligands and their receptors. Dev. Dyn. 223, 180-192.
48. Hoth C.F., Milunsky A., Lipsky N., Sheffer R., Clarren S.K. and Baldwin C.T. (1993). Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am. J. Hum. Genet. 52, 455-462.
49. Huynh-Do U., Stein E., Lane A.A., Liu H., Cerretti D.P. and Daniel T.O. (1999). Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through alphavbeta3 and alpha5beta1 integrins. EMBO J. 18, 2165-2173.
50. Iida S., Rao P.H., Nallasivam P., Hibshoosh H., Butler M., Louie D.C., Dyomin V., Ohno H., Chaganti R.S. and Dalla-Favera R. (1996). The t (9; 14)(p13; q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 88, 4110-4117.
51. Iskikiriyama S. (1993). Gene for Waardenburg syndrome type I is located at 2q35, not at 2q37.3. Am. J. Med. Genet. 46, 608.
52. Iwamasa H., Ohta K., Yamada T., Ushijima K., Terasaki H. and Tanaka H. (1999). Expression of Eph receptor tyrosine kinases and their ligands in chick embryonic motor neurons and hindlimb muscles. Dev. Growth Differ. 41, 685-698.
53. Jostes B., Walther C. and Gruss P. (1990). The murine paired box gene, Pax7, is expressed specifically during the development of the nervous and muscular system. Mech. Dev. 33, 27-37.
54. Kamaraju A.K., Bertolotto C., Chebath J. and Revel M. (2002). Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling. J. Biol. Chem. 277, 15132-15141.
55. Kawakami A., Kimura-Kawakami M., Nomura T. and Fujisawa H. (1997). Distributions of PAX6 and PAX7 proteins suggest their involvement in both early and late phases of chick brain development. Mech. Dev. 66, 119-130.
56. Kay P.H. and Ziman M.R. (1999). Alternate Pax7 paired box transcripts which include a trinucleotide or a hexanucleotide are generated by use of alternate 3′ intronic splice sites which are not utilized in the ancestral homologue. Gene 230, 55-60.
57. Kelly K.M., Womer R.B. and Barr F.G. (1998). PAX3-FKHR and PAX7-FKHR gene fusions in rhabdomyosarcoma. J. Pediatr. Hematol. Oncol. 20, 517-518.
58. Kioussi C., Gross M.K. and Gruss P. (1995). Pax3: A paired domain gene as a regulator in PNS myelination. Neuron 15, 553-562.
59. Kojima N., Tachida Y. and Tsuji S. (1997). Two polysialic acid synthases, mouse ST8Sia II and IV, synthesize different degrees of polysialic acids on different substrate glycoproteins in mouse neuroblastoma Neuro2a cells. J. Biochem. (Tokyo) 122, 1265-1273.
60. Kozmik Z., Sure U., Ruedi D., Busslinger M. and Aguzzi A. (1995). Deregulated expression of PAX5 in medulloblastoma. Proc. Natl. Acad. Sci. USA 92, 5709-5713.
61. Krauss S., Johansen T., Korzh V. and Fjose A. (1991). Expression of the zebrafish paired box gene pax [zf-b] during early neurogenesis. Development 113, 1193-1206.
62. Kroll T.G., Sarraf P., Pecciarini L., Chen C.J., Mueller E., Spiegelman B.M. and Fletcher J.A. (2000). PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma. Science, 9, 1357-1360.
63. Krull C.E. (1998). Inhibitory interactions in the patterning of trunk neural crest migration. Ann. NY Acad. Sci. 857, 13-22.
64. Lai K.O., Ip F.C. and Ip N.Y. (1999). Identification and characterization of splice variants of ephrin-A3 and ephrin-A5. FEBS Lett. 458, 265-269.
65. Mansouri A., Stoykova A. and Gruss P. (1994). Pax genes in development. J. Cell Sci. Suppl. 18, 35-42.
66. Mansouri A., Stoykova A., Torres M. and Gruss P. (1996). Dysgenesis of cephalic neural crest derivatives in Pax-/- mutant mice. Development 122, 831-838.
67. Marcelle C., Wolf J. and Bronner-Fraser M. (1995). The in vivo expression of the FGF receptor FREK mRNA in avian myoblasts suggests a role in muscle growth and differentiation. Dev. Biol. 172, 100-114.
68. Marin O., Blanco M.J. and Nieto M.A. (2001). Differential expression of Eph receptors and ephrins correlates with the formation of topographic projections in primary and secondary visual circuits of the embryonic chick forebrain. Dev. Biol. 234, 289-303.
69. Mayanil C.S.K., George D., Mania-Farnell B., Bremer C.L., McLone D.G. and Bremer E.G. (2000). Overexpression of murine Pax3 increases NCAM polysialylation in a human medulloblastoma cell line. J. Biol. Chem. 275, 23259-23266.
70. Mayanil C.S.K., George D., Mania-Farnell B., Bremer C.L., McClone D.G. and Bremer E.G. (2001). Microarray analysis detects novel Pax3 downstream target genes. J. Biol. Chem. 276, 49299-49309.
71. McArdle L., Rafferty M., Maelandsmo G., Bergin O., Farr C.J., Dervan P.A., O'Loughlin S., Herlyn M. and Easty D.J. (2001). Protein tyrosine phosphotase genes downregulated in melanoma. J. Invest. Dermatol. 117, 1255-1260.
72. Miao H., Burnett E., Kinch M., Simon E. and Wang B. (2000). Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat. Cell Biol. 2, 62-69.
73. Middel P., Gunawan B., Gross A.J., Radzun H.J. and Füzesi L. (2000). Chromosome abnormalities in a primary adult embryonal rhabdomyosarcoma of the prostate. Histopathology 37, 378-380.
74. Mooy C.M., Luyten G.P., De Jong P.T., Jensen O.A., Luider T.M., Van Der Ham F. and Bosman F.T. (1995). Neural cell adhesion molecule distribution in primary and metastatic uveal melanoma. Hum. Pathol. 26, 1185-1190.
75. Nikolova Z., Djonov V., Zuercher G., Andres A.C. and Ziemiecki A. (1998). Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland Morphogenesis. J. Cell Sci. 111, 2741-2751.
76. Olegard C., Mandahl N., Heim S., Willen H., Leifson B. and Mitelman F. (1992). Embryonal rhabdomyosarcoma with 100 chromosomes but no structural aberrations. Cancer Genet. Cytogen. 60, 198-201.
77. Pandey A., Shao H., Marks R.M., Polverini P.J. and Dixit V. (1995). Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. Science 268, 567-569.
78. Perl A.K., Dahl U., Wilgenbus P., Cremer H., Semb H. and Christofori G. (1999). Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells. Nat. Med. 5, 286-291.
79. Phimister E.G., Culverwell A., Patel K. and Kemshead J.T. (1994). Tissue-specific expression of neural cell adhesion molecule (NCAM) may allow differential diagnosis of neuroblastoma from embryonal rhabdomyosarcoma. Eur. J. Cancer 30A, 1552-1558.
80. Polito P., Dal Cin P., Scoit R., Brock P., Van Eyken P. and Van Den Berghe H. (1999). Embryonal rhabdomyosarcoma with only numerical chromosome changes. Case report and review of the literature. Cancer Genet. Cytogen. 109, 161-165.
81. Puig S., Ruiz A., Lazaro C., Castel T., Lynch M., Palou J., Vilalta A., Weissenbach J., Mascaro J.M. and Estivill X. (1995). Chromosome 9p deletions in cutaneous malignant melanoma tumors: The minimal deleted region involves markers outside the p16 (CDKN2) gene. Am. J. Hum. Genet. 57, 395-402.
82. Reed J.A., Finnerty B. and Albino A.P. (1999). Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression. Am. J. Pathol. 155, 549-555.
83. Roesler J., Srivatsan E., Moatamed F., Peters J. and Livingston E.H. (1997). Tumor suppressor activity of neural cell adhesion molecule in colon carcinoma. Am. J. Surg. 174, 251-257.
84. Rutishauser U., Acheson A., Hall A.K., Mann D.M. and Sunshine J. (1998). The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science 240, 53-57.
85. Schäfer B.W. and Mattei M.G. (1993). The human paired domain gene PAX7 (Hup 1) maps to chromosome 1p35- 1p36.2. Genomics 17, 249-251.
86. Schlondorff J. and Blobel C.P. (1999). Metalloprotease-disintegrins: Modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J. Cell Sci. 112, 3603-3617.
87. Scholl F.A., Kamarashev J., Murmann O.V., Geertsen R., Dummer R. and Schafer B.W. (2001). PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res. 61, 823-826.
88. Schulte T.W., Toretsky J.A., Ress E., Helman L. and Neckers L.M. (1997). Expression of PAX7 in Ewing's sarcoma family of tumors. Biochem. Mol. Med. 60, 121-126.
89. Seale P., Sabourin L.A., Girgus-Gabardo A., Mansouri A., Gruss P. and Rudnicki M.A. (2000). Pax7 is required for the specification of myogenic satellite cells. Cell 102, 777-786.
90. Seo H., Saetre B.O., Havik B., Ellingsen S. and Fjose A. (1998). The zebrafish Pax3 and Pax7 homologues are highly conserved, encode multiple isoforms and show dynamic segment-like expression in the developing brain. Mech. Dev. 70, 49-63.
91. Soler A.P., Johnson K.R., Wheelock M.J. and Knudsen K.A. (1993). Rhabdomyosarcoma-derived cell lines exhibit aberrant expression of the cell-cell adhesion molecules N-CAM, N-cadherin, and cadherin-associated proteins. Exp. Cell Res. 208, 84-93.
92. Springer T.A. (1990). Adhesion receptors of the immune system. Nature 346, 425-434.
93. Stadler H.S., Higgins K.M. and Capecchi M.R. (2001). Loss of Eph-receptor expression correlates with loss of cell adhesion and chondrogenic capacity in Hoxa13 mutant limbs. Development 128, 4177-4188.
94. Storms S.D. and Rutishauser U. (1998). A role for polysialic acid in neural cell adhesion molecule heterophilic binding to proteoglycans. J. Biol. Chem. 273, 27124-27129.
95. Stoykova A. and Gruss P. (1994). Roles of Pax-genes in developing and adult brain as suggested by expression patterns. J. Neurosci. 14, 1395-1412.
96. Stuart E.T., Kioussi C., Aguzzi A. and Gruss P. (1995). PAX5 expression correlates with increasing malignancy in human astrocytomas. Clin. Cancer Res. 1, 207-214.
97. Swartz M.E., Eberhart J., Pasquale E.B. and Krull C.E. (2001). EphA4/ephrin-A5 interactions in muscle precursor cell migration in the avian forelimb. Development 128, 4669-4680.
98. Tanaka F., Otake Y., Nakagawa T., Miyahara R., Li M., Yanagihara K., Nakayama J., Fujimoto I., Ikenaka K. and Wada H. (2000). Expression of polysialic acid and STX, a human polysialyltransferase, is correlated with tumor progression in non-small cell lung cancer. Cancer Res. 60, 3072-3080.
99. Tang X.X., Brodeur G.M., Campling B.G. and Ikegaki N. (1999). Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma. Clin. Cancer Res. 5, 455-460.
100. Tassabehji M., Read A.P., Newton V.E., Patton M., Gruss P., Harris R. and Strachan T. (1993). Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2. Nat. Genet. 3, 26-30.
101. Thomas M., Ziman M., Papadimitriou J. and Beazley L. (2001). Neural cell differentiation induced by the expression of the developmental gene, PAX7. Proc. Aust. Neurosci. Soc. 12, 147.
102. Tremblay P., Dietrich S., Mericskay M., Schubert F.R., Li Z. and Paulin D. (1998). A crucial role for Pax3 in the development of the hypaxial musculature and the long-range migration of muscle precursors. Dev. Biol. 203, 49-61.
103. Tsukamoto K., Nakamura Y. and Niikawa N. (1994). Isolation of two isoforms of the PAX3 gene transcripts and their tissue- specific alternative expression in human adult tissues. Hum. Genet. 93, 270-274.
104. Underhill D.A. and Gros P. (1997). The paired-domain regulates DNA binding by the homeodomain within the intact Pax-3 protein. J. Biol. Chem. 272, 14175-14182.
105. Vachtenheim J. and Novotna H. (1999). Expression of genes for micropthalmia isoforms, PAX3 and MSG1, in human melanomas. Cell Mol. Biol. 45, 1075-1082.
106. Vogan K.J. and Gros P. (1997). The C-terminal subdomain makes an important contribution to the DNA binding activity of the Pax-3 paired domain. J. Biol. Chem. 272, 28289-28295.
107. Vorobyov E., Mertsalov I., Dockhorn-Dworniczak B., Dworniczak B. and Horst J. (1997). The genomic organisation and the full coding region of the human PAX7 gene. Genomics 45, 168-174.
108. Wang Y., Jones F.S., Krushe L.A. and Edelman G.M. (1996). Embryonic expression patterns of the neural cell adhesion molecule gene are regulated by homeodomain binding sites. Proc. Natl. Acad. Sci. USA 93, 1892-1896.
109. Williams B.A. and Ordahl C.P. (1994). Pax-3 expression in segmental mesoderm marks early stages in myogenic cell specification. Development 120, 785-796.
110. Wybenga-Groot L.E., Baskin B., Ong S.H., Tong J., Pawson T. and Sicheri F. (2001). Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell 106, 745-757.
111. Yasumoto K., Yokoyama K., Takahashi K., Tomita Y. and Shibahara S. (1997). Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes. J. Biol. Chem. 272, 503-509.
112. Zelinski D.P., Zantek N.D., Stewart J.C., Irizarry A.R. and Kinch M.S. (2001). EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res. 61, 2301-2306.
113. Zettersten E., Sagebiel R.W., Miller J.R., Tallapureddy S., Leong S.P. and Kashani-Sabet M. (2002). Prognostic factors in patients with thick cutaneous melanoma (> 4 mm). Cancer 94, 1049-1056.
114. Zhao C., Snellman E., Jansen C. and Hemminki K. (2002). In situ repair of cyclobutane pyrimidine dimers in skin and melanocytic nevi of cutaneous melanoma patients. Int. J. Cancer 98, 331-334.
115. Ziman M. and Kay P. (1998). Differential expression of four alternative Pax7 paired box transcripts is influenced by organ- and strain-specific factors in adult mice. Gene 217, 77-81.
116. Ziman M.R., Fletcher S. and Kay P.H. (1997). Alternate Pax7 transcripts are expressed specifically in skeletal muscle, brain and other organs of adult mice. Int. J. Biochem. Cell Biol. 29, 1029-1036.
117. Ziman M.R., Thomas M., Jacobsen P. and Beazley L. (2001). A key role for Pax7 transcripts in determination of muscle and nerve cells. Exp. Cell Res. 268, 220-229.
118. Ziman M.R., Rodgers J., Lukehurst S. Hancock D., Dunlop S. and Beazley L. (2003). A dorso-ventral gradient of Pax6 in the developing retina suggests a role in topographic map formation. Cev. Brain Res. (in press).